HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fatemeh Jamshidi Selected Research

Eyelid Diseases

1/2022The Efficacy of Kohl (Surma) and Erythromycin in Treatment of Blepharitis: An Open-Label Clinical Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fatemeh Jamshidi Research Topics

Disease

1Eyelid Diseases
01/2022
1Blepharitis
01/2022
1Rheumatoid Arthritis
01/2019
1Organophosphate Poisoning
11/2018
1Diarrhea
02/2018
1Critical Illness (Critically Ill)
02/2018
1Hypersensitivity (Allergy)
05/2013
1Multiple Sclerosis
03/2013
1Thalassemia
01/2011
1beta-Thalassemia (Cooley's Anemia)
01/2011

Drug/Important Bio-Agent (IBA)

1Erythromycin (Erycette)FDA LinkGeneric
01/2022
1lead sulfide (kohl)IBA
01/2022
1Interleukin-2 (IL2)IBA
01/2019
1CytokinesIBA
01/2019
1Therapeutic UsesIBA
11/2018
1Magnesium Sulfate (Sulfate, Magnesium)FDA LinkGeneric
11/2018
1PrebioticsIBA
02/2018
1Immunoglobulin E (IgE)IBA
05/2013
1AllergensIBA
03/2013
1Fetal Hemoglobin (Hemoglobin F)IBA
01/2011
1GlobinsIBA
01/2011

Therapy/Procedure

2Length of Stay
11/2018 - 02/2018
1Traditional Medicine (Folk Remedies)
01/2022
1Enteral Nutrition (Feeding, Tube)
02/2018